We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+3.1%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$26.4B
AUM Growth
+$634M
Cap. Flow
+$1.1B
Cap. Flow %
4.16%
Top 10 Hldgs %
16.91%
Holding
1,174
New
163
Increased
578
Reduced
215
Closed
152

Sector Composition

Rank Sector Weight
1 Healthcare 23.87%
2 Technology 22.49%
3 Financials 11.08%
4 Consumer Discretionary 10.4%
5 Industrials 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DPZ icon
901
Domino's
DPZ
$11B
$866K ﹤0.01%
2,414
-34,107
-93% -$13.5M
FHTX icon
902
Foghorn Therapeutics
FHTX
$285M
$862K ﹤0.01%
180,333
+158,810
+738% +$872K
STE icon
903
Steris
STE
$20.9B
$846K ﹤0.01%
3,828
-12,924
-77% -$3.16M
HUBS icon
904
HubSpot
HUBS
$10.5B
$844K ﹤0.01%
3,457
+1,155
+50% +$324K
IDXX icon
905
Idexx Laboratories
IDXX
$42.9B
$818K ﹤0.01%
1,455
-12,172
-89% -$7.81M
ZM icon
906
Zoom
ZM
$25.8B
$798K ﹤0.01%
9,925
+5,296
+114% +$444K
SOFI icon
907
SoFi Technologies
SOFI
$21.1B
$785K ﹤0.01%
49,462
+27,396
+124% +$577K
ADT icon
908
ADT
ADT
$5.16B
$784K ﹤0.01%
+119,386
New +$896K
ALL icon
909
Allstate
ALL
$66.9B
$783K ﹤0.01%
3,775
+32
+0.9% +$6.56K
PFG icon
910
Principal Financial Group
PFG
$23.6B
$772K ﹤0.01%
8,569
+4,494
+110% +$411K
CADL icon
911
Candel Therapeutics
CADL
$700M
$768K ﹤0.01%
+156,700
New +$853K
RPRX icon
912
Royalty Pharma
RPRX
$26.1B
$756K ﹤0.01%
15,755
+8,319
+112% +$364K
VYGR icon
913
Voyager Therapeutics
VYGR
$187M
$749K ﹤0.01%
+193,984
New +$764K
CXM icon
914
Sprinklr
CXM
$1.33B
$746K ﹤0.01%
+124,253
New +$771K
CCEP icon
915
Coca-Cola Europacific Partners
CCEP
$46.5B
$738K ﹤0.01%
8,134
+4,305
+112% +$414K
SNA icon
916
Snap-on
SNA
$20.9B
$737K ﹤0.01%
2,029
+1,075
+113% +$398K
BETA
917
Beta Technologies Inc
BETA
$4.2B
$735K ﹤0.01%
50,000
ASTS icon
918
AST SpaceMobile
ASTS
$16.8B
$730K ﹤0.01%
+8,805
New +$831K
P
919
Everpure Inc
P
$24.8B
$725K ﹤0.01%
12,277
+6,524
+113% +$442K
BF.B icon
920
Brown-Forman Class B
BF.B
$12B
$709K ﹤0.01%
26,803
-3,354
-11% -$90.1K
TSN icon
921
Tyson Foods
TSN
$20.2B
$707K ﹤0.01%
11,041
+5,813
+111% +$361K
WST icon
922
West Pharmaceutical
WST
$23.1B
$703K ﹤0.01%
2,806
-7,282
-72% -$1.81M
NVR icon
923
NVR
NVR
$17.2B
$699K ﹤0.01%
106
+56
+112% +$408K
LEN icon
924
Lennar Class A
LEN
$20.4B
$694K ﹤0.01%
7,993
-117,079
-94% -$12.7M
CPB icon
925
Campbell Soup
CPB
$6.51B
$687K ﹤0.01%
30,839
+936
+3% +$24K

Similar funds

Woodline Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Woodline Partners held 1,174 positions worth $26.4B, up 2.5% from $25.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Woodline Partners deployed $1.1B of net new capital in Q1 2026, opening 163 new positions and adding to 578 existing holdings. Its largest new stake was SSR Mining: 3,518,756 shares worth $103M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Keysight, an estimated $222M trimmed.

  • Woodline Partners's largest Q1 2026 buy was SSR Mining: 3,518,756 shares worth $103M.
  • Woodline Partners added most to Alphabet (Google) Class A in Q1 2026, an estimated $156M increase.
  • Woodline Partners's biggest Q1 2026 reduction was Keysight, cutting an estimated $222M.
  • Woodline Partners fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $1.01B.
  • Woodline Partners's ten largest holdings make up 17% of its $26.4B portfolio in Q1 2026.
  • Woodline Partners opened 163 new positions and closed 152 in Q1 2026.
  • Woodline Partners's portfolio value rose 2.5% quarter-over-quarter to $26.4B.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.